|
||||||||||||||||||||||||||||||||||
[發(fā)表評(píng)論] [本類其他產(chǎn)品] [本類其他供應(yīng)商] [收藏] |
銷售商: 上海皓元生物醫(yī)藥科技有限公司 | 查看該公司所有產(chǎn)品 >> |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。
CAS No. : 115104-28-4
MCE 國(guó)際站:MK-571
產(chǎn)品活性:MK-571 (L-660711) 是一種口服有效、選擇性的和競(jìng)爭(zhēng)性的白三烯 D4 (LTD4) 受體拮抗劑,在豚鼠和人肺膜中的 Ki 值分別為 0.22 和 2.1 nM。MK-571 也是一種 MRP4 和 ABCC1 (MRP1) 抑制劑。MK-571 可抑制構(gòu)成性和抗原刺激的 S1P 釋放。
研究領(lǐng)域:GPCR/G Protein
作用靶點(diǎn):Leukotriene Receptor | LPL Receptor
In Vitro: MK571 (15 μM, 1 h) markedly suppresses constitutive and Ag-stimulated S1P secretion from RBL-2H3 cells and mast cells, and inhibits Fluo-3 efflux.
In Vivo: MK-571 (0-0.5 mg/kg, orally, once) produces dose-dependent inhibition of the duration of antigen-induced dyspnea in conscious sensitized rats treated with methysergide (3 μg/kg).
MK-571 (0-1 mg/kg, orally, once) blocks LTD4- and Ascaris-induced bronchoconstriction in conscious squirrel monkeys.
MK-571 (0-25 mg/kg, orally, daily, for 2 more weeks) shows reversal of hypoxic pulmonary hypertension (PH), and protects mice from hypoxic PH.
相關(guān)產(chǎn)品:Bioactive Compound Library Plus | GPCR/G Protein Compound Library | Immunology/Inflammation Compound Library | Orally Active Compound Library | Anti-Pulmonary Fibrosis Compound Library | Cancer Stem Cells Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Highly Selective Inhibitors Library | Anti-Drug-Resistant Compound Library | Multi-Target Compound Library | Bioactive Compound Library Max | Fingolimod hydrochloride | Sphingosine-1-phosphate | MK-571 sodium | Poloxamer 407 (F127) | Siponimod | JTE-013 | 1-Oleoyl lysophosphatidic acid sodium | Ozanimod | Ki16425 | Montelukast sodium | MK-886 | BMS-986278 | BMS-986020 | PF-543 Citrate | Zafirlukast | SLF1081851 | Ponesimod | Etrasimod | TY-52156 | AM966 | Leukotriene B4 | AM095 | SEW2871 | CAY10444 | W146 TFA | Tryptanthrin
熱門產(chǎn)品線:重組蛋白 | 藥物篩選 | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種全球獨(dú)家化合物庫,我們致力于為全球科研客戶提供前沿最全的高品質(zhì)小分子活性化合物;
• 50,000 多種高選擇性抑制劑、激動(dòng)劑涉及各熱門信號(hào)通路及疾病領(lǐng)域;
• 產(chǎn)品種類涵蓋各種重組蛋白,多肽,常用試劑盒 ,更有 PROTAC、ADC 等特色產(chǎn)品,廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項(xiàng)目;
• 提供虛擬篩選,離子通道篩選,代謝組學(xué)分析檢測(cè)分析,藥物篩選等專業(yè)技術(shù)服務(wù);
• 設(shè)有專業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控、驗(yàn)證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項(xiàng)質(zhì)檢報(bào)告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國(guó)客戶實(shí)驗(yàn)驗(yàn)證;
• Nature, Cell, Science 等多種頂級(jí)期刊及制藥專利收錄了MCE客戶的科研成果;
• 專業(yè)團(tuán)隊(duì)跟蹤最新的制藥及生命科學(xué)研究進(jìn)展,為您提供全球最新的活性化合物;
• 與世界各大制藥公司及知名科研機(jī)構(gòu)建立了長(zhǎng)期的合作。